Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IN RE: Androgel Antitrust Litigation (No. II)
Case Number:
1:09-md-02084
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Alston & Bird
- Arnold & Porter
- Baker & Hostetler
- Berger Montague
- Blaxter Blackman
- Buchanan Ingersoll
- Cozen O'Connor
- Doffermyre Shields
- Faruqi & Faruqi
- Foley & Lardner
- Garland Samuel
- Garwin Gerstein
- Grant & Eisenhofer
- Greenberg Traurig
- Gustafson Gluek
- Hagens Berman
- Hangley Aronchick
- Heim Payne
- Holzer & Holzer
- Johnson Fistel
- Kenny Nachwalter
- Kirkland & Ellis
- Lacy Price
- Littler Mendelson
- Locke Lord
- Marcus & Shapira
- Mayer Brown
- Miller Shah LLP
- Morris Manning
- Munger Tolles
- Odom & Des Roches
- Pomerantz LLP
- Rawlings & Associates PLLC
- Schnader Harrison
- Skadden Arps
- Smith Segura
- Sperling & Slater
- Stites & Harbison
- Vaughan & Murphy
- Wexler Boley
- White & Case
- Williams & Connolly
Companies
- AbbVie Inc.
- Allergan PLC
- Capital Wholesale Drug Co.
- Cardinal Health Inc.
- CVS Health Corp.
- Fraternal Order of Police
- Giant Eagle Inc.
- Health Net Inc.
- H‑E‑B LP
- J.M. Smith Corp.
- McKesson Corp.
- Meijer Inc.
- Paddock Laboratories Inc.
- Par Pharmaceutical Cos. Inc.
- Perrigo Co. PLC
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Safeway Inc.
- Supervalu Inc.
- Teva Pharmaceutical Industries Ltd.
- United Food & Commercial Workers International Union
Government Agencies
Sectors & Industries:
-
August 11, 2015
Drugmakers Fight FTC Bid For Privileged Antitrust Risk Docs
AbbVie Products LLC and other drugmakers being sued by the Federal Trade Commission and private plaintiffs over patent pay-for-delay settlements for testosterone drug AndroGel have told a Georgia federal court to reject a bid that would force them to turn over details of their settlement negotiations.
-
July 27, 2015
FTC Asks AbbVie, Others For Deal Docs In Pay-For-Delay Suit
The Federal Trade Commission and private plaintiffs suing AbbVie Products LLC and other drugmakers over patent pay-for-delay settlements for testosterone drug AndroGel moved Friday to force the companies to turn over details of their settlement negotiations.
-
October 24, 2013
AndroGel Judge Says It's Time To Revive Class Fight
A Georgia federal judge said Wednesday that he would overturn his dismissal of so-called pay-for-delay claims against Actavis Inc. and others in a putative class action over AndroGel in light of a recent U.S. Supreme Court ruling — if the Eleventh Circuit agrees to remand the case.
-
September 28, 2012
Sham Litigation Claims Nixed In Androgel Pay-For-Delay MDL
A Georgia federal judge on Friday dismissed antitrust allegations that Solvay Pharmaceuticals Inc. filed sham patent infringement litigation against generic rivals in order to delay the entry of competing versions of Androgel from the market through a reverse payment settlement.
-
May 18, 2011
Firms, Experts Allowed To Stay In AndroGel MDL
Solvay Pharmaceuticals Inc. and two other drugmakers on Tuesday lost bids to disqualify two expert witnesses and two law firms from multidistrict litigation in Georgia over whether the companies' AndroGel patent settlements violated antitrust law.
-
March 24, 2011
Solvay Wants Firms, Expert Removed In AndroGel Suit
Solvay Pharmaceuticals Inc. and two other drugmakers on Tuesday sought to disqualify an expert witness and two law firms from multidistrict litigation in Georgia over whether the companies' AndroGel patent settlements violated antitrust law.
-
September 17, 2010
Generics Subject To Solvay Sham Litigation Claims
A federal judge has kept alive claims alleging generics makers Par Pharmaceutical Cos. Inc. and Paddock Laboratories Inc. engaged in sham litigation by agreeing not to release competing versions of Solvay Pharmaceuticals Inc.’s testosterone supplement AndroGel.
-
June 10, 2010
FTC Fights Nixing Of AndroGel Reverse Payment Suit
The Federal Trade Commission is challenging the dismissal of its claims accusing Solvay Pharmaceuticals Inc. of paying generic-drug makers not to compete with its testosterone supplement AndroGel, continuing the fight over so-called reverse payment settlements in the pharmaceutical industry.
-
March 08, 2010
AndroGel Buyer Seeks 2nd Shot At Pay-For-Delay Suit
An indirect purchaser of Solvay Pharmaceuticals Inc.'s testosterone supplement AndroGel has asked for leave to amend a recently dismissed putative class action accusing the drugmaker of keeping generics rivals out of the market by paying them through patent settlements.
-
February 23, 2010
AndroGel Reverse Payment Suits Thrown Out
A federal judge has thrown out suits by the Federal Trade Commission and private plaintiffs challenging patent settlements in which Solvay Pharmaceuticals Inc. paid generic-drug makers not to compete with its testosterone supplement AndroGel, joining other federal courts in upholding drug companies' right to make so-called reverse payment deals.